Post COVID‐19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation

Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay

(2021) Jin-an Zhou et al.   Current Medical Science

Environmental triggers for connective tissue disease

(2021) Maria De Santis et al.   CURRENT OPINION IN RHEUMATOLOGY

New-onset IgG autoantibodies in hospitalized patients with COVID-19

(2021) Sarah Esther Chang et al.   Nature Communications

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

(2021) Michael J Peluso et al.   CLINICAL INFECTIOUS DISEASES

High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia

(2020) Carmine Gazzaruso et al.   CLINICAL RHEUMATOLOGY

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

(2020) Antoine Guilmot et al.   JOURNAL OF NEUROLOGY

SARS‐CoV‐2 infection as a trigger of autoimmune response

(2020) Maria C. Sacchi et al.   CTS-Clinical and Translational Science